ADA Standards Updated With Renal Guidance Based on CREDENCE ADA Standards Updated With Renal Guidance Based on CREDENCE
New renal management guidance is based on data from the recently reported Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy (CREDENCE) trial.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news
More News: Canagliflozin | Cardiology | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Invokana